Immigration is key to biotech.
Nadia Bey 24, freelance reporter with a BA in Biology and Global Health from Duke University, 2-15-2024, "How Immigration Policy Changes Can Affect Biopharma Hiring," https://www.biospace.com/article/how-immigration-policy-changes-can-affect-biopharma-hiring/
Most international students who want to remain in the U.S. plan to pursue H-1B visas, Chen noted. But the legal cap makes this a challenge, and many students aren’t aware of alternatives.
“If we want to truly encourage STEM professionals to come to the United States for studies and a career, we need to eliminate the unpredictability of a random H-1B lottery,” Feist wrote.
Despite the challenges, Feist said that throughout her time working in immigration law, companies have been receptive to working with employees going through the immigration process. “World-class biomedical companies rely heavily on having access to the global ‘best and brightest’ in order to continue driving innovation and progress.”